Cargando…
Biologic treatments in Behçet's disease
Behçet's disease (BD) significantly increases morbidity and mortality, especially in young men. While vascular involvement is the most frequent cause of mortality, ocular involvement, which can cause visual loss, is the most important cause of morbidity in BD. Immunosuppressive treatment is the...
Autores principales: | Alibaz-Öner, Fatma, Direskeneli, Haner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Research and Education Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176232/ https://www.ncbi.nlm.nih.gov/pubmed/33687828 http://dx.doi.org/10.5152/eurjrheum.2020.20138 |
Ejemplares similares
-
Update on the Diagnosis of Behçet’s Disease
por: Alibaz-Oner, Fatma, et al.
Publicado: (2022) -
Advances in the Treatment of Behcet’s Disease
por: Alibaz-Oner, Fatma, et al.
Publicado: (2021) -
Decreasing incidence and severity of Behçet’s disease: a changing trend in epidemiological spectrum possibly associated with oral health
por: MUMCU, Gonca, et al.
Publicado: (2020) -
The assessment of contributing factors to oral ulcer presence in Behçet’s disease: Dietary and non-dietary factors
por: İris, Merve, et al.
Publicado: (2018) -
Risk of tuberculosis is increased in Behçet’s disease compared to other rheumatological disorders after anti-TNFα treatments: a case series and review of the literature
por: GAZEL, Ümmügülsüm, et al.
Publicado: (2021)